Items where authors include "Torres, A"

Article

Glasbey, JC, Nepogodiev, D, Simoes, JFF et al. (1869 more authors) (2021) Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic. Colorectal Disease, 23 (3). pp. 732-749. ISSN 1462-8910

Glasbey, JC, Nepogodiev, D, Omar, O et al. (3453 more authors) (2020) Delaying surgery for patients with a previous SARS-CoV-2 infection. British Journal of Surgery, 107 (12). e601-e602. ISSN 0007-1323

Noviello, S, Corey, GR, Holland, TL et al. (9 more authors) (2020) A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections. Journal of Medical Microbiology. 001177. ISSN 0022-2615

Huang, DB, Magnet, S, De Angelis, S et al. (6 more authors) (2019) Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe. Diagnostic Microbiology and Infectious Disease, 93 (2). ISSN 0732-8893

Huang, DB, Corey, GR, Holland, TL et al. (8 more authors) (2018) Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections. International Journal of Antimicrobial Agents, 52 (2). pp. 233-240. ISSN 0924-8579

Holland, TL, O'Riordan, W, McManus, A et al. (12 more authors) (2018) A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study). Antimicrobial Agents and Chemotherapy, 62 (5). e02580-17. ISSN 0066-4804

Huang, DB, O'Riordan, W, Overcash, JS et al. (10 more authors) (2018) A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1. Clinical Infectious Diseases, 66 (8). pp. 1222-1229. ISSN 1058-4838

Huang, DB, File, TM, Dryden, M et al. (3 more authors) (2018) Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe. Diagnostic Microbiology and Infectious Disease, 90 (4). pp. 329-334. ISSN 0732-8893

Huang, DB, Duncan, LR, Flamm, RK et al. (5 more authors) (2018) The Effect of Pulmonary Surfactant on the In Vitro Activity of Iclaprim Against Common Respiratory Bacterial Pathogens. Diagnostic Microbiology and Infectious Disease, 90 (1). pp. 64-66. ISSN 0732-8893

Reynolds, MP, Pask, AJD, Hoppitt, WJE orcid.org/0000-0003-0815-5720 et al. (73 more authors) (2017) Strategic crossing of biomass and harvest index—source and sink—achieves genetic gains in wheat. Euphytica, 213 (11). ISSN 0014-2336

Huang, DB, File, TM, Torres, A et al. (5 more authors) (2017) A Phase II Randomized, Double-Blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-Positive Pathogens. Clinical Therapeutics, 39 (8). pp. 1706-1718. ISSN 0149-2918

Sivakumar, S, Taccone, FS, Desai, KA et al. (2497 more authors) (2016) ESICM LIVES 2016: part two. Intensive Care Medicine Experimental, 4 (S1).